Clinical TrialID 4962
A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.
NCT00203125
Parkinson's Disease
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 4962
- Evidence Id
- 4962
- Core Evidence Id
- 4962
- Source Clinical Trial Id
- 4942
- Herb2 Clinical Trial Id
- HBCT004942
- Nct Id
- NCT00203125
- Title
- A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.
- Status
- Completed
- Phase
- Phase 3
- Study Result
- No
- Study Condition
- Parkinson's Disease
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: rasagiline mesylate|OTHER: tyramine
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Double
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Child, Adult, Older_Adult
- Enrollment
- 55
- Outcome Measure
- An increase in systolic blood pressure of > 30mmHg from the mean baseline value (documented by at least 3 consecutive measurements). Or Bradycardia with a heart rate below 40 beats per minute, 26 weeks
- Sponsor Collaborator
- Teva Branded Pharmaceutical Products R&D, Inc.
- Funded By
- INDUSTRY
- Location
- Other Id
- TVP - 1012/133a
- Start Date
- 2000-10
- Primary Completion Date
- 2003-01
- Completion Date
- 2003-01
- First Posted
- 2005-09-20
- Results First Posted
- Last Update Posted
- 2011-04-12
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00203125
- Title Cn
- Title En
- A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.
- Bilingual Status
- semi_complete